Transgenic expression of cyclin-dependent kinase 4 results in epidermal hyperplasia, hypertrophy, and severe dermal fibrosis

American Journal of Pathology

Volumn 159, Issue 1, 2001, Pages 369-379

  Miliani De Marval, Paula L ^a   Gimenez Conti, Irma B ^a   LaCava, Margaret ^a   Martinez, Luis A ^a   Conti, Claudio J ^a   Rodriguez Puebla, Marcelo L ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CDK4 PROTEIN, HUMAN; CDK4 PROTEIN, MOUSE; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 4; CYCLINE; KERATIN; ONCOPROTEIN; RETINOBLASTOMA PROTEIN;

ANIMAL; ARTICLE; EPIDERMIS; FIBROSIS; FUNCTIONS OF THE SKIN AND ITS APPENDAGES; GENETICS; HUMAN; HYPERPLASIA; HYPERTROPHY; METABOLISM; MOUSE; PATHOLOGY; PHYSIOLOGY; SKIN; TRANSGENIC MOUSE;

ANIMALS; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASES; CYCLINS; EPIDERMIS; FIBROSIS; HUMANS; HYPERPLASIA; HYPERTROPHY; KERATINS; MICE; MICE, TRANSGENIC; PROTO-ONCOGENE PROTEINS; RETINOBLASTOMA PROTEIN; SKIN; SKIN PHYSIOLOGY;

EID: 0035404133     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)61703-8     Document Type: Article

References (58)

1. Sherr CJ: G1 phase progression: cyclin on cue. Cell 1994, 79:551-555
2. Sherr CJ: Mammalian G1 cyclins. Cell 1993, 73:1059-1065
3. Sherr CJ: D-type cyclins. Trends Biochem Sci 1995, 20:187-190
4. Nevins JR: E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 1992, 258:424-429
5. Harbour JW, Luo RX, Dei Santi A, Postigo AA, Dean DC: Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell 1999, 98:859-869
6. Zhang HS, Gavin M, Dahiya A, Postigo AA, Ma D, Luo RX, Harbour JW, Dean DC: Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF. Cell 2000, 101:79-89
7. Kitagawa MH, Higasashi HK, Jung I, Suzuki-Takahashi M, Ikeda K, Tamai I, Kato K, Segawa E, Yoshida S, Nishimura S, Taya Y: The consensus motif for phosphorylation by cyclin D1-CDK4 is different from that for phosphorylation by cyclin A/E-CDK2. EMBO J 1996, 15:7060-7069
8. Xiong Y, Hannon G, Zhang H, Casso D, Kobayashi R, Beach D: p21 is a universal inhibitor of cyclin kinases. Nature 1993, 366:701-704
9. Xiong Y: Why are there so many CDK inhibitors? Biochim Biophys Acta 1996, 1288:1-5
10. Hirama T, Koeffler HP: Role of the cyclin dependent kinase inhibitors in the development of cancer. Blood 1995, 86:841-854
11. Meyer CA, Jacobs HW, Datar SA, Du W, Edgar BA, Lehner CF: Drosophila Cdk4 is required for normal growth and is dispensable for cell cycle progression. EMBO J 2000, 19:4533-4542
12. Datar SA, Jacobs HW, de la Cruz AF, Lehner CF, Edgar BA: The Drosophila cyclinD-Cdk4 complex promotes cellular growth. EMBO J 2000, 19:4543-4554
13. Sicinski P, Donaher J, Parker S, Li T, Fazeli A, Gardener H, Haslam S, Bronson R, Elledge S, Weinberg R: Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 1995, 82:621-630
14. Fantl V, Stamp G, Andrews A, Rosewell I, Dickson C: Mice lacking cyclin d1 are small and show defects in eye and mammary gland development. Genes Dev 1995, 9:2364-2372
15. Sicinski P, Donaher J, Geneg Y, Parker S, Garder H, Park M, Robker R, Richards J, McGinnis L, Biggers J, Epping J, Bronson R, Elledege S, Weinberg R: Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis. Nature 1996, 384:470-474
16. Zwijsen R, Wientjens E, Klompmaker R, van der Sman J, Bernards R, Michalides R: CDK-independent activation of estrogen receptor by cyclin D1. Cell 1997, 88:405-415
17. Knudsen K, Cavenee W, Arden K: D-type cyclins complex bind with the androgen receptor and inhibits its transcriptional transactivation ability. Cancer Res 1999, 59:2297-2301
18. McHannon C, Suthiphongchai T, DiRenzo J, Ewen M: P/CAF associates with cyclin D1 and potentiates its activation of the estrogen receptor. Proc Natl Acad Sci USA 1999, 96:5382-5387
19. Neuman E, Ladha M, Lin N, Upton T, Miller S, DiRenzo J, Pesteli R, Hinds P, Dowdy S, Brown M, Ewen M: Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4. Mol Cell Biol 1997, 17:5338-5347
20. Ohta M, Nagai H, Shimizu M, Rasio D, Berd D, Mastrangelo M, Singh AD, Shields JA, Shields CJ, Croce CM: Rarity of somatic and germline mutations of the cyclin-dependent kinase 4 inhibitor gene. CDK41, in melanoma. Cancer Res 1994, 54:5269-5272
21. Soufir N, Avril MF, Chompret A, Demenais F, Bombled J, Spatz A, Stoppa-Luonnet D, Bernard J, Bressac-de Paillerets R: Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. Hum Mol Genet 1998, 7:209-216
22. Wölfel T, Hauer M, Schneider J, Serrano M, Wölfel C, Klehmann-Hieb E, De Plaen E, Hankeln T, Meyer zum Büschenfelde KH, Beach D: A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science 1995, 269:1281-1284
23. He J, Allen JR, Collins VP, Allalunis-Turner MJ, Godbout R, Day RS, James CD: CDK4 amplification is an alternative mechanism to p16 homozygous deletion in glioma cell lines. Cancer Res 1994, 54:5804-5807
24. Ichimura K, Schmidt EE, Goike HM, Collins VP: Human glioblastomas with no alterations of the CDKN2A and CDK4 genes have frequent mutations of the retinoblastoma gene. Oncogene 1996, 13:1065-1072
25. Rodriguez-Puebla ML, Robles AI, Johnson DG, LaCava M, Conti CJ: Synchronized proliferation induced by TPA treatment of mouse skin: an in vivo model for cell cycle regulation. Cell Growth Differ 1998, 9:31-39
26. Rodriguez-Puebla ML, LaCava M, Gimenez-Conti IB, Jonhson DG, Conti CJ: Deregulated expression of cell-cycle proteins during premalignant progression in SENCAR mouse skin. Oncogene 1998, 17:2251-2258
27. Robles AI, Larcher F, Whalin RB, Murillas R, Richie E, Gimenez-Conti IB, Jorcano JL, Conti CJ: Expression of cyclin D1 in epithelial tissues of transgenic mice results in epidermal hyperproliferation and severe thymic hyperplasia. Proc Natl Acad Sci USA 1996, 93:7634-7638
28. Rodriguez-Puebla ML, LaCava M, Conti C: Cyclin D1 overexpression in mouse epidermis increases cyclin-dependent kinase activity and cell proliferation in vivo but does not affect skin tumor development. Cell Growth Differ 1999, 10:467-472
29. Rodriguez-Puebla ML, LaCava M, Miliani de Marval PL, Jorcano JL, Richie E, Conti CJ: Cyclin D2 overexpression in transgenic mice induces thymic and epidermal hyperplasia whereas cyclin D3 expression results only in epidermal hyperplasia. Am J of Pathol 2000, 157:1039-1050
30. Ramirez A, Bravo A, Jorcano J, Vidal M: Sequences 5′ of the bovine keratin 5 gene direct tissue- and cell-type-specific expression of a lacZ gene in the adult and during development. Differentiation 1994, 58:53-64
31. Woodcock-Mitchell J, Eichner R, Nelson WG, Sun T: Immunolocalization of keratin polypeptides in human epidermis using monoclonal antibodies. J Cell Biol 1982, 95:580-588
32. Roop D, Hawley-Nelson P, Cheng CK, Yuspa SH: Keratin gene expression in mouse epidermis and cultured epidermal cells. Proc Natl Acad Sci USA 1983, 80:716-720
33. Schweizer J, Kinjo M, Furstenberger G, Winter H: Sequential expression of mRNA-encoded keratin sets in neonatal mouse epidermis: basal cells with properties of terminally differentiating cells. Cell 1984, 37:159-170
34. Knapp B, Rentrop M Schweizer J, Winter H: Three cDNA sequences ol mouse type I keratins. Cellular localization of the mRNAs in normal and hyperproliterative tissues. J Biol Chem 1987, 262:938-945
35. Moll R, Moll I, Franke W: Differences of expression of cytokeratin polypeptides in various epithelial skin tumors. Arch Dermato Res 1984, 276:349-363
36. Weiss RA, Eichner R, Sun T: Monoclonal antibody analysis of keratin expression in epidermal diseases: a 48- and 56-kdalton keratin as molecular markers for hyperproliferative keratinocytes. J Cell Biol 1984, 98:1397-1406
37. Matsushine H, Ewen ME Strom DK, Kato J-Y, Hanks SK, Roussel MF, Sherr CJ: Identification and properties of an atypical catalytic subunit (p34/cdk4) for mammalian D type 61 cyclins. Cell 1992, 71:323-334
38. Bates S, Parry D, Bonetta L, Vousden K, Dickson C, Peters G: Absence of cyclin D/cdk complexes in cells lacking functional retinoblastoma protein. Oncogene 1994, 9:1633-1640
39. Bates S, Bonetta L, MacAllan D, Parry D, Holder A, Dickson C, Peters G: CDK6 (PLSTIRE) and CDK4 (PSK-J3) are a distinct set of the cyclin-dependent kinases that associate with cyclin D1. Oncogene 1994, 9:71-79
40. Ewen M: The cell cycle and the retinoblastoma protein family. Cancer Metastasis Rev 1994, 13:45-66
41. Hannon GJ, Demetrick D, Beach D: Isolation of the Rb-related p130 through its interaction with CDK2 and cyclins. Genes Dev 1993, 7:2378-2391
42. Ewen ME, Xing VG, Lawrence JB, Livingston DW: Molecular cloning, chromosomal mapping, and expression of the cDNA for p107, a retinoblastoma gene product-related protein. Cell 1991, 66:1155-1164
43. McConnell B, Gregory F, Stott F, Hara E, Peters G: Induced expression of p16Ink4a inhibits both CDK4- and CDK2-associated kinase activity by reassortment of cyclin-CDK-inhibitor complexes. Mol Cell Biol 1999, 19:1981-1989
44. Tsutsui T, Hesabi B, Moons DS, Pandolfi P, Hansel K, Koff A. Kiyokawa H: Targeted disruption of CDK4 delays cell cycle entry with enhanced p27Kip1 activity. Mol Cell Biol 1999, 19:7011-7019
45. Schmit E, Ichimura K, Reifenberger G: CdkN2 (p16/MTST1) gene deletion or Cdk4 amplification occurs in the majority of glioblastomas. Cancer Res 1994, 54:6321-6324
46. Klein-Szanto AJP: Morphological evaluation of tumor promoter effects on mammalian skin. Mechanisms of Tumor Promotion, Tumor Promotion and Skin Carcinogenesis, Edited by TJ Slaga. Boca Raton, CRC Press, 1984, pp 42-72
47. Holland EC, Hively WP, Gallo V, Varmus HE: Modeling mutations in the G1 arrest pathway in human gliomas: overexpression of CDK4 but not loss of INK4a-ARF induces hyperploidy in cultured mouse astrocytes. Genes Dev 1998, 12:3644-3649
48. Hassig CA, Fleischer TC, Billin AN, Schreiber SL, Ayer DE: Histone deacetylase activity is required for full transcriptional repression by msin3a. Cell 1997, 89:341-347
49. Brehem A, Miska EA, McCance DJ, Reid JL, Bannister AJ, Kouzarides T: Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 1998, 391:597-601
50. Magnaghi JL, Groisman R, Naguibnueva I, Robin P, Lorain S, Le VJ, Troalen F, Trouche D, Harel BA: Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 1998, 391: 601-605
51. Munz B, Smola H, Engelhard F, Bleuel K, Brauchle M, Lein I, Evans LW, Huylebroeck D, Balling R, Werner S: Overexpression of activin A in the skin of transgenic mice reveals new activities of activin in epidermal morphogenesis, dermal fibrosis and wound repair. EMBO J 1999, 18:5205-5215
52. Roop DR, Mehrel T, Krieg K, Nakazawa H, Cheng CK, Yuspa SH: Keratin expression in mouse epidermal tumors. Carcinog Compr Surv 1989, 11:257-271
53. Paladini RD, Coulombe PA: Directed expression of keratin 16 to the progenitor basal cells of transgenc mouse skin delays skin maturation. J Cell Biol 1998, 142:1035-1051
54. Geng Y, Whonskey W, Park MY, Bronson RT, Medema RH, Li T, Weinberg RA, Sicinski P: Rescue of cyclin D1 deficiency by knockin cyclin E. Cell 1999, 97:767-777
55. Sherr CJ, Roberts JM: CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 1999, 10:1491-1502
56. Ewen ME, Sluss HK, Whitehouse L, Livingston DM: TGFB inhibition of Cdk4 synthesis is linked to cell cycle arrest. Cell 1993, 74:1009-1020
57. Coleman KG, Wautlet BS, Morrissey D, Mulheron J, Sedman SA, Brinkley P, Price S, Webster KR: Identification of CDK4 sequences involved in cyclin D1 and p16 binding. J Bol Chem 1997, 272:18869-18874
58. Parry D, Mahony D, Wills K, Lees E: Cyclin-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors. Mol Cell Biol 1999, 19:1775-1783